(Q46798764)

25 December 2017

title

Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion (English)

1 reference

25 December 2017

author

Xavier Langlois

5

1 reference

25 December 2017

author name string

C Norman

1

1 reference

25 December 2017

S R G Beckett

2

1 reference

25 December 2017

C H Spicer

3

1 reference

25 December 2017

D Ashton

4

1 reference

25 December 2017

G W Bennett

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

21 January 2008

1 reference

25 December 2017

Journal of Psychopharmacology

published in

1 reference

25 December 2017

volume

22

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

300-307

1 reference

25 December 2017

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood–brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Neurotensin: Antinocisponsive action in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

The effects of intra-accumbens neurotensin on sensorimotor gating

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Pro-dopamine effects of neurotensin on sensorimotor gating deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Down-regulation of neurotensin receptors after ligand-induced internalization in rat primary cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Repeated administration of the neurotensin analogue NT69L induces tolerance to its suppressant effect on conditioned avoidance behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Anatomy and Mechanisms of Neurotensin‐Dopamine Interactions in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Reduced CSF neurotensin concentration in drug-free schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Automatic registration of behaviour related to dopamine and noradrenaline transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

Neurotensin blocks certain amphetamine-induced behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107083838

21 January 2018

Identifiers

DOI

10.1177/0269881107083838

1 reference

25 December 2017

1 reference

25 December 2017